These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28099960)

  • 1. Prognostic Factors after Curative Resection for Single-Lesion Hepatocellular Carcinoma in Patients with Normal Liver Function: A Historical Cohort Study.
    Shimoda M; Tago K; Kato M; Aoki T; Kubota K
    Dig Surg; 2017; 34(4):281-288. PubMed ID: 28099960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
    J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of long-term survival and recurrence after curative resection of hepatocellular carcinoma.
    Hanazaki K; Matsushita A; Nakagawa K; Misawa R; Amano J
    Hepatogastroenterology; 2005; 52(62):552-7. PubMed ID: 15816476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.
    Hirokawa F; Hayashi M; Asakuma M; Shimizu T; Inoue Y; Uchiyama K
    Surg Oncol; 2016 Mar; 25(1):24-9. PubMed ID: 26979637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.
    Hanazaki K; Kajikawa S; Shimozawa N; Matsushita A; Machida T; Shimada K; Yazawa K; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2005; 52(62):524-9. PubMed ID: 15816471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
    Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function.
    Kang CM; Choi GH; Kim DH; Choi SB; Kim KS; Choi JS; Lee WJ
    J Surg Res; 2010 May; 160(1):81-9. PubMed ID: 19577249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of neutrophil to lymphocyte ratio on survival for hepatocellular carcinoma after curative resection.
    Hung HC; Lee JC; Cheng CH; Wu TH; Wang YC; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    J Hepatobiliary Pancreat Sci; 2017 Oct; 24(10):559-569. PubMed ID: 28846835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.
    Wakayama K; Kamiyama T; Yokoo H; Orimo T; Shimada S; Einama T; Kamachi H; Taketomi A
    J Surg Oncol; 2017 Mar; 115(3):324-329. PubMed ID: 28192617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma.
    Zhang J; Zhou ZG; Huang ZX; Yang KL; Chen JC; Chen JB; Xu L; Chen MS; Zhang YJ
    Chin J Cancer; 2016 Mar; 35():25. PubMed ID: 26956022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.
    Shiba H; Furukawa K; Fujiwara Y; Futagawa Y; Haruki K; Wakiyama S; Ishida Y; Misawa T; Yanaga K
    Anticancer Res; 2013 Feb; 33(2):705-9. PubMed ID: 23393371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function.
    Li Y; Ruan DY; Yi HM; Wang GY; Yang Y; Jiang N
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):477-84. PubMed ID: 26459723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.
    Ng KKC; Chok KSH; Chan ACY; Cheung TT; Wong TCL; Fung JYY; Yuen J; Poon RTP; Fan ST; Lo CM
    Br J Surg; 2017 Dec; 104(13):1775-1784. PubMed ID: 29091283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.